These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16781151)

  • 1. Identification of small-molecule inhibitors of the Abeta-ABAD interaction.
    Xie Y; Deng S; Chen Z; Yan S; Landry DW
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4657-60. PubMed ID: 16781151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer's disease treatment.
    Hroch L; Guest P; Benek O; Soukup O; Janockova J; Dolezal R; Kuca K; Aitken L; Smith TK; Gunn-Moore F; Zala D; Ramsay RR; Musilek K
    Bioorg Med Chem; 2017 Feb; 25(3):1143-1152. PubMed ID: 28082069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer's disease treatment.
    Hroch L; Benek O; Guest P; Aitken L; Soukup O; Janockova J; Musil K; Dohnal V; Dolezal R; Kuca K; Smith TK; Gunn-Moore F; Musilek K
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3675-8. PubMed ID: 27287370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of human ABAD/HSD10 with a bound inhibitor: implications for design of Alzheimer's disease therapeutics.
    Kissinger CR; Rejto PA; Pelletier LA; Thomson JA; Showalter RE; Abreo MA; Agree CS; Margosiak S; Meng JJ; Aust RM; Vanderpool D; Li B; Tempczyk-Russell A; Villafranca JE
    J Mol Biol; 2004 Sep; 342(3):943-52. PubMed ID: 15342248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface plasmon resonance and nuclear magnetic resonance studies of ABAD-Abeta interaction.
    Yan Y; Liu Y; Sorci M; Belfort G; Lustbader JW; Yan SS; Wang C
    Biochemistry; 2007 Feb; 46(7):1724-31. PubMed ID: 17253767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease.
    Chen X; Yan SD
    IUBMB Life; 2006 Dec; 58(12):686-94. PubMed ID: 17424907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics simulations of the amyloid-beta binding alcohol dehydrogenase (ABAD) enzyme.
    Marques AT; Fernandes PA; Ramos MJ
    Bioorg Med Chem; 2008 Nov; 16(21):9511-8. PubMed ID: 18835182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The consequences of mitochondrial amyloid beta-peptide in Alzheimer's disease.
    Muirhead KE; Borger E; Aitken L; Conway SJ; Gunn-Moore FJ
    Biochem J; 2010 Feb; 426(3):255-70. PubMed ID: 20175748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mitochondrial enzyme ABAD and its role in the development and treatment of Alzheimer's disease].
    Benek O; Musílek K; Kuca K
    Ceska Slov Farm; 2012 Aug; 61(4):144-9. PubMed ID: 23251955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders.
    Benek O; Hroch L; Aitken L; Gunn-Moore F; Vinklarova L; Kuca K; Perez DI; Perez C; Martinez A; Fisar Z; Musilek K
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):665-670. PubMed ID: 29536773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoprotective role of mitochondrial amyloid beta peptide-binding alcohol dehydrogenase against a cytotoxic aldehyde.
    Murakami Y; Ohsawa I; Kasahara T; Ohta S
    Neurobiol Aging; 2009 Feb; 30(2):325-9. PubMed ID: 17707551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial β-amyloid in Alzheimer's disease.
    Borger E; Aitken L; Muirhead KE; Allen ZE; Ainge JA; Conway SJ; Gunn-Moore FJ
    Biochem Soc Trans; 2011 Aug; 39(4):868-73. PubMed ID: 21787315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.
    Meredith JE; Thompson LA; Toyn JH; Marcin L; Barten DM; Marcinkeviciene J; Kopcho L; Kim Y; Lin A; Guss V; Burton C; Iben L; Polson C; Cantone J; Ford M; Drexler D; Fiedler T; Lentz KA; Grace JE; Kolb J; Corsa J; Pierdomenico M; Jones K; Olson RE; Macor JE; Albright CF
    J Pharmacol Exp Ther; 2008 Aug; 326(2):502-13. PubMed ID: 18499745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of inhibition at multiple stages of amyloid-beta self-assembly provides mechanistic insight.
    Davis TJ; Soto-Ortega DD; Kotarek JA; Gonzalez-Velasquez FJ; Sivakumar K; Wu L; Wang Q; Moss MA
    Mol Pharmacol; 2009 Aug; 76(2):405-13. PubMed ID: 19483107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)/amyloid-beta binding alcohol dehydrogenase (ABAD).
    Powell AJ; Read JA; Banfield MJ; Gunn-Moore F; Yan SD; Lustbader J; Stern AR; Stern DM; Brady RL
    J Mol Biol; 2000 Oct; 303(2):311-27. PubMed ID: 11023795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer's Disease.
    Morsy A; Trippier PC
    J Med Chem; 2019 May; 62(9):4252-4264. PubMed ID: 30444369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico-designed novel non-peptidic ABAD L
    Viswanath ANI; Kim T; Jung SY; Lim SM; Pae AN
    Chem Biol Drug Des; 2017 Dec; 90(6):1041-1055. PubMed ID: 28660722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic role of mitochondrial [correction of mitochondral] amyloid-beta peptide.
    Chen JX; Yan SD
    Expert Rev Neurother; 2007 Nov; 7(11):1517-25. PubMed ID: 17997700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Benzothiazole-based Ureas as 17β-HSD10 Inhibitors, A Potential Alzheimer's Disease Treatment.
    Aitken L; Benek O; McKelvie BE; Hughes RE; Hroch L; Schmidt M; Major LL; Vinklarova L; Kuca K; Smith TK; Musilek K; Gunn-Moore FJ
    Molecules; 2019 Jul; 24(15):. PubMed ID: 31362457
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of the mitochondrial enzyme ABAD restores the amyloid-β-mediated deregulation of estradiol.
    Lim YA; Grimm A; Giese M; Mensah-Nyagan AG; Villafranca JE; Ittner LM; Eckert A; Götz J
    PLoS One; 2011; 6(12):e28887. PubMed ID: 22174920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.